BioSpace News Archive

Longeveron Inc. today announced the appointment of seasoned global pharmaceutical leader Wa’el Hashad as Chief Executive Officer.

ContraFect Corporation announced that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $10.0 million of its common stock in a registered direct offering and warrants to purchase common stock in a concurrent private placement.

Verismo Therapeutics , a clinical-stage CAR T company, Penn spinout, and pioneer of the novel KIR-CAR platform technology, today announced a $7M pre-Series A financing round.

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at the Raymond James & Associates’ 44th Annual Institutional Investors Conference, scheduled for March 5-8, 2023, at the JW Marriott Grande Lakes in Orlando.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the AMP-270 Phase 2 study of Ampligen as a therapy for locally advanced pancreatic cancer (“LAPC”) has opened its first clinical site and has begun recruiting patients.

NanoSpot.ai, a biotechnology diagnostics company, announces the full commercial release of its SARS-CoV-2 Total Antibody Test.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida.

In January 2022, warrants corresponding to a dilution of 0.2% of the number of outstanding shares were deregistered.

AbbVie (NYSE: ABBV) will participate in the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, 2023.

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable MRI system, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the latest update of its Swoop® system software.